initial public offering (IPO) was subscribed 52.59 times on the last day of offer that concluded on December 15. Stock market experts predict that Medplus shares may list at a moderate premium of 15-20%. "After a mediocre listing of Metro shoes & Shriram property, the overall market mood is not encouraging.
The business is still expected to list at a premium of ₹100-150 per share. According to current financials and profit growth, everything appears to be in order.
Any price above 1200 will make the stock overvalued so making fresh investments one should avoid, because this is a high-capital-intensive business, margins may stay volatile.